A Randomized Phase II Trial of Hypo-fractionated Intensity-Modulated Radiation Therapy (IMRT) Utilizing 2.5 Gy/Fraction Versus Standard- Fractionated IMRT, Concurrent With Carboplatin/Paclitaxel and Followed by Consolidation Durvalumab, for Subjects With Stage III Non-Small Cell Lung Cancer

Clinical Lung Cancer 2026

View at publisher

Authors: Krishna Reddy, Fen Wang, Y. Cao, Gregory N. Gan

DOI: 10.1016/j.cllc.2025.12.004

Cited by: 0

References: 15

Fields of Study & Subjects

Lung Cancer Diagnosis and Treatment Effects of Radiation Exposure Lung Cancer Research Studies

References 15